Sponsor Overview
Explore verified public information about University of Texas Southwestern Medical Center's expanded access programs, compassionate use policies, and patient eligibility pathways. This report aggregates official statements, independent research, and regulatory data to help patients, providers, and sponsors collaborate efficiently.
Unique references curated across 3 content categories.
ClinicalTrials.gov data sources power this status.
Dataset refreshed continuously through Right2Hope ETL pipelines.
Expanded Access Intelligence
Official Statements
Score contribution: 100 — 1 supporting sources.
“The Human Research Protection Program's Sponsor Investigator Support provides assistance to physicians who wish to treat patients with investigational drugs or devices outside of a clinical investigation.”
Past EAPs on ClinicalTrials.gov
Score contribution: 40 — 3 supporting sources.
Conditions: Soft Tissue Sarcoma
Conditions: Relapsed Neuroblastoma, Metastatic Pheochromocytoma
Conditions: Hydronephrosis, Multicystic-dysplastic Kidney
Partner with Right2Hope
Right2Hope helps sponsors translate regulatory programs into actionable patient access pathways. Connect with our team to publish new programs, streamline intake workflows, or align with providers seeking compassionate use options.